Results 211 to 220 of about 644,115 (313)

Synthesis and Evaluation of 1-Arylsulfonyl-3-piperazinone Derivatives as Factor Xa Inhibitors VI. A Series of New Derivatives Containing N,S- and N,SO2-Spiro Acetal Scaffolds

open access: bronze, 2007
Fumihiko Saitoh   +9 more
openalex   +2 more sources

UEG Week 2025 Poster Presentations

open access: yes
United European Gastroenterology Journal, Volume 13, Issue S8, Page S803-S1476, October 2025.
wiley   +1 more source

Development of a Medication-Use Evaluation Template for Andexanet Alfa in the Reversal of Anticoagulation With Factor Xa Inhibitors. [PDF]

open access: yesJ Pharm Pract
Fera T   +10 more
europepmc   +1 more source

Pathobiochemistry of Sepsis [PDF]

open access: yes, 1986
Duswald, Karl-Heimo   +5 more
core   +1 more source

Incremental economic burden associated with major bleeding among atrial fibrillation patients treated with factor Xa inhibitors

open access: yesJournal of Medical Economics, 2017
S. Deitelzweig   +4 more
semanticscholar   +1 more source

Efficacy and Safety of Andexanet Alfa for Bleeding Caused by Factor Xa Inhibitors: A Systematic Review and Meta-Analysis. [PDF]

open access: yesCureus, 2021
Shrestha DB   +7 more
europepmc   +1 more source

The impact of a three-factor prothrombin complex concentrate on the anticoagulatory effects of the factor Xa inhibitor edoxaban [PDF]

open access: hybrid, 2015
Karen Brown   +7 more
openalex   +1 more source

Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of deep vein thrombosis.

open access: yesCochrane Database of Systematic Reviews, 2015
L. Robertson, P. Kesteven, J. McCaslin
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy